Amgen (AMGN) Debt Ratio (2009 - 2026)
Amgen (AMGN) recorded quarterly Debt Ratio of 0.62 in Q1 2026, up 2.8% quarter-over-quarter from 0.6 in Q4 2025, and down 3.49% on a YoY basis from 0.64 in Q1 2025.
Amgen (AMGN) Debt Ratio (2009 - 2026) Analysis & Trends
Amgen's Debt Ratio history runs 18 years deep, the most recent figure standing at 0.62 for Q1 2026.
- In Q1 2026, Debt Ratio fell 3.49% year-over-year to 0.62; the TTM figure through Mar 2026 stood at 0.62 (down 3.49% YoY), while the FY2025 annual figure was 0.6, down 7.89% from the prior year.
- Debt Ratio was 0.62 for Q1 2026 at Amgen, up from 0.6 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.69 in Q1 2023 to a low of 0.6 in Q4 2022.
- Historically, Debt Ratio has averaged 0.64 across 5 years, with a median of 0.64 in 2025.
- The sharpest annual moves came in 2022 and 2025: Debt Ratio climbed 19.12% in 2022, then declined 8.88% in 2025.
- A 5-year view of Debt Ratio shows it stood at 0.6 in 2022, then rose by 11.21% to 0.67 in 2023, then retreated by 1.6% to 0.65 in 2024, then fell by 7.89% to 0.6 in 2025, then climbed by 2.8% to 0.62 in 2026.
- The last three Debt Ratio figures came in at 0.62 (Q1 2026), 0.6 (Q4 2025), and 0.61 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn | -0.22 |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn | 0.37 |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn | 0.27 |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn | 0.47 |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn | 0.38 |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn | 0.62 |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn | 0.39 |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn | 0.31 |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn | 0.51 |
| 10 | Novartis Ag | 108.28 Bn | 107.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.62 |
| Dec 31, 2025 | 0.60 |
| Sep 30, 2025 | 0.61 |
| Jun 30, 2025 | 0.64 |
| Mar 31, 2025 | 0.64 |
| Dec 31, 2024 | 0.65 |
| Sep 30, 2024 | 0.66 |
| Jun 30, 2024 | 0.69 |
| Mar 31, 2024 | 0.69 |
| Dec 31, 2023 | 0.67 |
| Sep 30, 2023 | 0.67 |
| Jun 30, 2023 | 0.68 |
| Mar 31, 2023 | 0.69 |
| Dec 31, 2022 | 0.60 |
| Sep 30, 2022 | 0.61 |
| Jun 30, 2022 | 0.62 |
| Mar 31, 2022 | 0.62 |
| Dec 31, 2021 | 0.54 |
| Sep 30, 2021 | 0.58 |
| Jun 30, 2021 | 0.55 |